Protecting Patient Access to Cancer and Complex Therapies
This bill aims to change how certain drugs, including cancer treatments, are paid for. It introduces a rebate system for drug manufacturers, which could lower costs for insured patients. The goal is to maintain access to vital therapies while managing drug prices.
Key points
Manufacturers of selected drugs, including cancer treatments, will be required to pay rebates, potentially lowering drug prices.
The bill aims to reduce out-of-pocket costs for patients for drugs subject to price negotiations.
These changes are intended to ensure patients continue to have access to necessary therapies while controlling drug expenditures.
Expired
Citizen Poll